CHERCHER

Avis
La loi sur le droit d'auteur et les politiques propres à chacune des maisons d'édition ne nous permet pas d'offrir l'accès au texte intégral.

Jeronimo C, Langelier M-F, Zeghouf M, Cojocaru M, Bergeron D, Baali D, Forget D, Mnaimneh S, Davierwala AP, Pootoolal J, Chandy M, Canadien V, Beattie BK, Richards DP, Workman JL, Hughes TR, Greenblatt J, Coulombe B

RPAP1, a novel human RNA polymerase II-associated protein affinity purified with recombinant wild-type and mutated polymerase subunits.

Mol Cell Biol,

24(16):7043-7058, 2004.


Larochelle P, Lamarre-Cliche M
Hypertensive Vascular Disease.
In : The IUPHAR Compendium of Basic Principles For Pharmacological Research in Humans. Edited by Patrick du Souich, Michael Orme, Sergio Erill. Irvine, Calif. : International Union of Basic and Clinical Pharmacology, 2004. P. 87-105.

Schiller PW

Opioid peptide-derived delta antagonists, inverse delta agonists, and mixed mu agonist/delta antagonists. In : The Delta Receptor.
Edited by Kwen-Jen Chang, Frank Porreca, James H. Woods. New York, N.Y. : Marcel Dekker, Inc., 2004. P. 191-210.

Amiri F, Virdis A, Fritsch Neves M, Iglarz M, Seidah NG, Touyz RM, Reudelhuber TL, Schiffrin EL

Endothelium-restricted overexpression of human endothelin-1 causes vascular remodeling and endothelial dysfunction.

Circulation

110(15):2233-2240, 2004.


Ao Z, Yao X, Cohen ÉA
Assessment of the role of the central DNA flap in human immunodeficiency virus type 1 replication by using a single-cycle replication system.
J Virol,78(6):3170-3177, 2004.

Aries A, Paradis P, Lefebvre C, Schwartz RJ, Nemer M

Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity.

Proc Natl Acad Sci U S A,

101(18):6975-6980, 2004.


Assmann G, Corsini A, Davignon J, Grundy SM, Libby P, März W, Mason RP, Nissen SE, Pedersen TR, Ridker PM, Riesen W, Schaefer EJ, Waters D
Cholesterol-lowering with statins: Are they all the same?
Drugs of Today,40(6):555-561, 2004.

Azizi M, Bissery A, Lamarre-Cliche M, Ménard J

Integrating drug pharmacokinetics for phenotyping individual renin response to angiotensin II blockade in humans.

Hypertension,

43(4):785-790, 2004.


Banes AK, Shaw S, Jenkins J, Redd H, Amiri F, Pollock DM, Marrero MB
Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli.
Am J Physiol Renal Physiol,286(4):F653-F659, 2004.

Beauchemin H, Blouin MJ, Trudel M

Differential regulatory and compensatory responses in hematopoiesis/erythropoiesis in alpha - and beta -globin hemizygous mice.

J Biol Chem,

279(19):19471-19480, 2004.


Béland M, Pilon N, Houle M, Oh K, Sylvestre J-R, Prinos P, Lohnes D

Cdx1 autoregulation is governed by a novel Cdx1-LEF1 transcription complex.

Mol Cell Biol,

24(11):5028-5038, 2004.


Ben Y, Smith AP, Schiller PW, Lee NM

Tolerance develops in spinal cord, but not in brain with chronic [Dmt1]DALDA treatment.

Br J Pharmacol,

143(8):987-993, 2004.


Benjannet S, Cromlish JA, Diallo K, Chrétien M, Seidah NG

The metabolism of ß-amyloid converting enzyme and ß-amyloid precursor protein processing.

Biochem. Biophys. Res. Commun.

325(1):235-242, 2004.


Benjannet S, Rhainds D, Essalmani R, Mayne J, Wickham L, Jin W, Asselin M-C, Hamelin J, Varret M, Allard D, Trillard M, Abifadel M, Tebon A, Attie AD, Rader DJ, Boileau C, Brissette L, Chrétien M, Prat A, Seidah NG

NARC-1/PCSK9 and its natural mutants: zymogen cleavage and effects on the low density lipoprotein (LDL) receptor and LDL-cholesterol.

J Biol Chem,

279(47):48865-48875, 2004.


Berezowska I, Lemieux C, Chung NN, Zelent B, Schiller PW
Dansylated analogues of the opioid peptide [Dmt1]DALDA: in vitro activity profiles and fluorescence parameters.
Acta Biochim Pol,51(1):107-113, 2004.

Bériault V, Clément J-F, Lévesque K, LeBel C, Yong X, Chabot B, Cohen ÉA, Cochrane AW, Rigby WFC, Mouland AJ

A late role for the association of hnRNP A2 with the HIV-1 hnRNP A2 response elements in genomic RNA, Gag and Vpr localization.

J Biol Chem,

279(42):44141-44153, 2004.


Binette J, Cohen EA

Recent Advances in the Understanding of HIV-1 Vpu Accessory Protein Functions.

Curr Drug Targets
Immune Endocr Metabol Disord,

4(4):297-307, 2004.


Bocchi B, Kenouch S, Lamarre-Cliche M, Muffat-Joly M, Capron MH, Fiet J, Morineau G, Azizi M, Bonvalet JP, Farman N

Impaired 11-{beta} hydroxysteroid dehydrogenase type 2 activity in sweat gland ducts in human essential hypertension.

Hypertension,

43(4):803-808, 2004.


Boisvert M, Bergeron A, Lazure C, Manjunath P

Isolation and characterization of gelatin-binding bison seminal vesicle secretory proteins.

Biol Reprod,

70(3):656-661, 2004.


Bouzeghrane F, Mercure C, Reudelhuber TL, Thibault G

{alpha}8{beta}1 integrin is upregulated in myofibroblasts of fibrotic and scarring myocardium.

J Mol Cell Cardiol,

36(3):343-353, 2004.


Callera GE, Montezano AC, Touyz RM, Zorn TMT, Carvalho MHC, Fortes ZB, Nigro D, Schiffrin EL, Tostes RC

ETA receptor mediates altered leukocyte-endothelial cell interaction and adhesion molecules expression in DOCA-salt rats.

Hypertension,

43(4):872-879, 2004.


Cao L-Z, Tang D-Q, Horb ME, Li S-W, Yang L-J
High glucose is necessary for complete maturation of Pdx1-VP16-expressing hepatic cells into functional insulin-producing cells.
Diabetes,53(12):3168-3178, 2004.

Chen CF, Goyette P, Lohnes D

RARgamma acts as a tumor suppressor in mouse keratinocytes.

Oncogene,

23(31):5350-5359, 2004.


Chen R, Relouzat F, Roncagalli R, Aoukaty A, Tan R, Latour S, Veillette A

Molecular dissection of 2B4 signaling: Implications for signal transduction by SLAM-related receptors.

Mol Cell Biol,

24(12):5144-5156, 2004.


Churchill GA, Airey DC, Allayee H, Angel JM, Attie AD, Beatty J, Beavis WD, Belknap JK, Bennett B, Berrettini W, Bleich A, Bogue M, Broman KW, Buck KJ, Buckler E, Burmeister M, Chesler EJ, Cheverud JM, Clapcote S, Cook MN, Cox RD, Crabbe JC, Crusio WE, Darvasi A, Deschepper CF, Doerge RW, Farber CR, Forejt J, Gaile D, Garlow SJ, Geiger H, Gershenfeld H, Gordon T, Gu J, Gu W, de Haan G, Hayes NL, Heller C, Himmelbauer H, Hitzemann R, Hunter K, Hsu HC, Iraqi FA, Ivandic B, Jacob HJ, Jansen RC, Jepsen KJ, Johnson DK, Johnson TE, Kempermann G, Kendziorski C, Kotb M, Kooy RF, Llamas B, Lammert F, Lassalle JM, Lowenstein PR, Lu L, Lusis A, Manly KF, Marcucio R, Matthews D, Medrano JF, Miller DR, Mittleman G, Mock BA, Mogil JS, Montagutelli X, Morahan G, Morris DG, Mott R, Nadeau JH, Nagase H, Nowakowski RS, O'hara BF, Osadchuk AV, Page GP, Paigen B, Paigen K, Palmer AA, Pan HJ, Peltonen-Palotie L, Peirce J, Pomp D, Pravenec M, Prows DR, Qi Z, Reeves RH, Roder J, Rosen GD, Schadt EE, Schalkwyk LC, Seltzer Z, Shimomura K, Shou S, Sillanpaa MJ, Siracusa LD, Snoeck HW, Spearow JL, Svenson K, Tarantino LM, Threadgill D, Toth LA, Valdar W, de Villena FP, Warden C, Whatley S, Williams RW, Wiltshire T, Yi N, Zhang D, Zhang M, Zou F

The Collaborative Cross, a community resource for the genetic analysis of complex traits.

Nat Genet,

36(11):1133-1137, 2004


Cloutier F, Ongali B, Campos MM, Thibault G, Neugebauer W, Couture R

Correlation between brain bradykinin receptor binding sites and cardiovascular function in young and adult spontaneously hypertensive rats.

Br J Pharmacol,

142(2):285-296, 2004.


Cloutier G, Daronat M, Savéry D, Garcia D, Durand L-G, Foster FS

Non-Gaussian statistics and temporal variations of the ultrasound signal backscattered by blood at frequencies between 10 and 58 MHz.

J Acoust Soc Am,

116(1):566-577, 2004.


Cloutier G, Soulez G, Qanadli SD, Teppaz P, Allard L, Qin Z, Cloutier F, Durand L-G

A multimodality vascular imaging phantom with fiducial markers visible in DSA, CTA, MRA, and ultrasound.

Med Phys,

31(6):1424-1433, 2004.


Cohn JS, Patterson BW, Uffelman KD, Davignon J, Steiner G

Rate of production of plasma and very-low-density lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensitivity.

J Clin Endocrinol Metab,

89(8):3949-3955, 2004.


Cohn JS, Rodriguez C, Jacques H, Tremblay M, Davignon J
Storage of human plasma samples leads to alterations in the lipoprotein distribution of apoC-III and apoE.
J Lipid Res,45(8):1572-1579, 2004.

Cohn JS, Tremblay M, Batal R, Jacques H, Rodriguez C, Steiner G, Mamer O, Davignon J

Increased apoC-III production is a characteristic feature of patients with hypertriglyceridemia.

Atherosclerosis,

177(1):137-145, 2004.


Coulombe B, Jeronimo C, Langelier M-F, Cojocaru M, Bergeron D
Interaction networks of the molecular machines that decode, replicate and maintain the integrity of the human genome.
Mol Cell Proteomics,3(9):851-856, 2004.

Daigle C, Martens FMAC, Girardot D, Dao HH, Touyz RM, Moreau P

Signaling of angiotensin II-induced vascular protein synthesis in conduit and resistance arteries in vivo.

BMC Cardiovasc Disord,

4(1):1-8, 2004.


Danilovich N, Maysinger D, Sairam MR
Perspectives on reproductive senescence and biological aging: Studies in genetically altered follitropin receptor knockout [FORKO] mice.
Exp Gerontol,39(11-12):1669-1678, 2004.

Danis C, Deschambeault J, Do Carmo S., Cohen ÉA, Rassart É, Lemay G
The tyrosine-based YXXØ targeting motif of murine leukemia virus envelope glycoprotein affects pathogenesis.
Virology,324(1):173-183, 2004.

Davidson D, Shi X, Zhang S, Wang H, Nemer M, Ono N, Ohno S, Yanagi Y, Veillette A

Genetic evidence linking SAP, the X-linked lymphoproliferative gene product, to src-related kinase FynT in T(H)2 cytokine regulation.

Immunity,

21(5):707-717, 2004.


Davidson W, McGibbon GA, White PW, Yoakim C, Hopkins JL, Guse I, Hambly DM, Frego L, Ogilvie WW, Lavallée P, Archambault J

Characterization of the binding site for inhibitors of the HPV11 E1-E2 protein interaction on the E2 transactivation domain by photoaffinity labeling and mass spectrometry.

Anal Chem,

76(7):2095-2102, 2004.


Davignon J

Beneficial cardiovascular pleiotropic effects of statins.

Circulation,

109(23 Suppl. 1):III-39-III-43, 2004.


Davignon J
Cardioprotective and other emerging effects of statins.
Int J Clin Pract,58(Suppl. 143):49-57, 2004.

Davignon J
Emphasis on pleiotropic effects, a new paradigm shift?
Coron Artery Dis,15(5):223-225, 2004.

Davignon J
The use of statins in atherosclerotic cardiovascular disease.
Semin Vasc Med,4(4):311-312, 2004.

Davignon J, Ganz P

Role of endothelial dysfunction in atherosclerosis.

Circulation,

109(23 Suppl. 1):III-27-III-32, 2004.


Davignon J, Jacob RF, Mason RP
The antioxidant effects of statins.
Coron Artery Dis,15(5):251-258, 2004.

Davignon J

The cardioprotective effects of statins.

Curr Atheroscler Rep,

6(1):27-35, 2004.


de Champlain J, Wu R, Girouard H, Karas M, EL Midaoui A, Laplante MA, Wu L

Oxidative stress in hypertension.

Clin Exp Hypertens,

26(7-8):593-601, 2004.


De Deken X, Raymond M

Constitutive activation of the PDR16 promoter in a Candida albicans azole-resistant clinical isolate overexpressing CDR1 and CDR2.

Antimicrob Agents Chemother,

48(7):2700-2703, 2004.


de Repentigny, L., Lewandowski, D., Jolicoeur, P.

Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection. 

Clin Microbiol Rev,

17(4):729-759, 2004.


Demers DL, Fournier F, Lemire M, Péladeau P, Prémont M-C, Roy DJ

Le réseautage de l'information de santé: Manuel pour la gestion des questions éthiques et sociales. Montréal, Qc : Institut de recherches cliniques de Montréal, Centre de bioéthique, 2004.

Deschepper CF, Olson JL, Otis M, Gallo-Payet N

Characterization of blood pressure and morphologic traits in cardiovascular-related organs in 13 different inbred mouse strains.

J Appl Physiol,

97(1):369-376, 2004.


Diep QN, Amiri F, Benkirane K, Paradis P, Schiffrin EL
Long-term effects of the PPAR{gamma} activator pioglitazone on cardiac inflammation in stroke-prone spontaneously hypertensive rats.
Can J Physiol Pharmacol,82(11):976-985, 2004.

Diep QN, Benkirane K, Amiri F, Cohn JS, Endemann D, Schiffrin EL

PPARalpha activator fenofibrate inhibits myocardial inflammation and fibrosis in angiotensin II-infused rats.

J Mol Cell Cardiol,

36(2):295-304, 2004.


Dubuc G, Chamberland A, Wassef H, Davignon J, Seidah NG, Bernier L, Prat A

Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia.

Arterioscler Thromb Vasc Biol,

24(8):1454-1459, 2004.


Dufour R
Lipid lowering agents.
In : The IUPHAR Compendium of Basic Principles For Pharmacological Research in Humans. Edited by Patrick du Souich, Michael Orme, Sergio Erill. Irvine, Calif. : International Union of Basic and Clinical Pharmacology, 2004. P. 106-117.

El Mabrouk M, Diep QN, Benkirane K, Touyz RM, Schiffrin EL
SAM68: a downstream target of angiotensin II signaling in vascular smooth muscle cells in genetic hypertension.
Am J Physiol Heart Circ Physiol,286(5):H1954-H1962, 2004.

Elijovich F, Laffer CL, Schiffrin EL, Gavras H, Amador E
Endothelin-aldosterone interaction and proteinuria in low-renin hypertension.
J Hypertens,22(3):573-582, 2004.

Endemann DH, Pu Q, De Ciuceis C, Savoia C, Virdis A, Fritsch Neves M, Touyz RM, Schiffrin EL

Persistent remodeling of resistance arteries in type 2 diabetic patients on antihypertensive treatment.

Hypertension,

43(2 Part. 2):399-404, 2004.


Endemann DH, Schiffrin EL

Nitric oxide, oxidative excess, and vascular complications of diabetes mellitus.

Curr Hypertens Rep,

6(2):85-89, 2004.


Endemann DH, Schiffrin EL

Endothelial dysfunction.

J Am Soc Nephrol,

15(8):1983-1992, 2004.


Endemann DH, Touyz RM, Iglarz M, Savoia C, Schiffrin EL

Eplerenone prevents salt-induced vascular remodeling and cardiac fibrosis in stroke-prone spontaneously hypertensive rats.

Hypertension,

43(6):1252-1257, 2004.


Ferrando AA, Herblot S, Palomero T, Hansen M, Hoang T, Fox EA, Look AT

Biallelic transcriptional activation of oncogenic transcription factors in T-cell acute lymphoblastic leukemia.

Blood,

103(5):1909-1911, 2004.


Fichna J, do-Rego J-C, Costentin J, Chung NN, Schiller PW, Kosson P, Janecka A

Opioid receptor binding and in vivo antinociceptive activity of position 3-substituted morphiceptin analogs.

Biochem Biophys Res Commun,

320(2):531-536, 2004.


Filip K, Oleszczuk M, Wójcik J, Chung NN, Schiller PW, Pawlak D, Zieleniak A, Parcinska A, Witkowska E, Izdebski J

Cyclic enkephalin and dermorphin analogues containing a carbonyl bridge.

J Pept Sci,

2004.


Filipp D, Leung BL, Zhang J, Veillette A, Julius M

Enrichment of lck in lipid rafts regulates colocalized fyn activation and the initiation of proximal signals through TCR{alpha}{beta}.

J Immunol,

172(7):4266-4274, 2004.


Forget D, Langelier M-F, Thérien C, Trinh V, Coulombe B

Photo-cross-linking of a purified preinitiation complex reveals central roles for the RNA polymerase II mobile clamp and TFIIE in initiation mechanisms.

Mol Cell Biol,

24(3):1122-1131, 2004.


Garcia D, Pibarot P, Landry C, Allard A, Chayer B, Dumesnil JG, Durand L-G
Estimation of aortic valve effective orifice area by Doppler echocardiography: Effects of valve inflow shape and flow rate.
J Am Soc Echocardiogr,17(7):756-765, 2004.

Gaudreault SB, Chabot C, Gratton J-P, Poirier J

The caveolin scaffolding domain modifies 2-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor binding properties by inhibiting phospholipase A2 activity.

J Biol Chem,

279(1):356-362, 2004.


Gauthier DJ, Gibbs BF, Rabah N, Lazure C

Utilization of a new biotinylation reagent in the development of a nondiscriminatory investigative approach for the study of cell surface proteins.

Proteomics,

4(12):3783-3790, 2004.


Girouard H, de Champlain J
Inhibitory effect of melatonin on {alpha}1-adrenergic-induced vasoconstriction in mesenteric beds of spontaneously hypertensive rats.
Am J Hypertens,17(4):339-346, 2004.

Girouard H, Denault C, Chulak C, de Champlain J
Treatment by N-acetylcysteine and melatonin increases cardiac baroreflex and improves antioxidant reserve.
Am J Hypertens,17(10):947-954, 2004.

Gonzalez M, de Champlain J
Hypertension artérielle non compliquée.
Le Médecin du Québec,39(9):85-90, 2004.

Goyer L
Innovation en santé cardiovasculaire : nouvel angle sur les facteurs psychosociaux et les maladies cardiovasculaires.
Les actualités du coeur,9(1):7-10, 2004.

Gratton J-P, Bernatchez P, Sessa WC

Caveolae and Caveolins in the Cardiovascular System.

Circ Res,

94(11):1408-1417, 2004.


Grover A, Sairam MR, Smith CE, Hermo L

Structural and functional modifications of Sertoli cells in the testis of adult follicle-stimulating hormone receptor knockout mice.

Biol Reprod,

71(1):117-129, 2004.


Guindon Y, Brazeau J-F
Diastereoselective mukaiyama and free radical processes for the synthesis of polypropionate units.
Org Lett,6(15):2599-2602, 2004.

Gutkowska J, Mukaddam-Daher S, Jankowski M, Schiller PW

The cardiovascular and renal effects of the potent and highly selective {mu} opioid agonist [Dmt1]DALDA. 

J Cardiovasc Pharmacol,

44(6):651-658, 2004.


Hanna Z, Priceputu E, Kay DG, Poudrier J, Chrobak P, Jolicoeur P
In vivo mutational analysis of the N-terminal region of HIV-1 Nef reveals critical motifs for the development of an AIDS-like disease in CD4C/HIV transgenic mice.
Virology,327(2):273-286, 2004.

Heckmann A, Waltzinger C, Jolicoeur P, Dreano M, Kosco-Vilbois MH, Sagot Y

IKK2 inhibitor alleviates kidney and wasting diseases in a murine model of human AIDS.

Am J Pathol,

164(4):1253-1262, 2004.


Hemmelgarn BR, Zarnke KB, Campbell NR, Feldman RD, McKay DW, McAlister FA, Khan N, Schiffrin EL, Myers MG, Bolli P, Honos G, Lebel M, Levine M, Padwal R
The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I - Blood pressure measurement, diagnosis and assessment of risk.
Can J Cardiol,20(1):31-40, 2004.

Hermann F, Ruschitzka FT, Schiffrin EL
Clinical trials report. CHARM-Preserved Trial
Curr Hypertens Rep,6(1):48-50, 2004.

Hirsch-Reinshagen V, Zhou S, Burgess BL, Bernier L, McIsaac SA, Chan JY, Tansley GH, Cohn JS, Hayden MR, Wellington CL

Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain.

J Biol Chem,

279(39):41197-41207, 2004.


Hospital V, Prat A

Nardilysin, a basic residues specific metallopeptidase that mediates cell migration and proliferation.

Protein and Peptide Letters,

11(5):501-508, 2004.


Iglarz M, Touyz RM, Viel EC, Amiri F, Schiffrin EL
Involvement of oxidative stress in the profibrotic action of aldosterone: Interaction wtih the renin-angiotension system.
Am J Hypertens,17(7):597-603, 2004.

Jolicoeur P, Yue P, Hanna Z, Simard M-C, Kay DG

Cardiac disease in HIV-1 Tg animals

in : AIDS and Heart Disease. Edited by Ronald R. Watson. New York, N.Y. : Marcel Dekker, 2004. P. 377-386.


Kuchel O

New insights into pseudopheochromocytoma and emotionally provoked hypertension

in : Secondary Hypertension: Clinical Presentation, Diagnosis, and Treatment. Edited by George A. Mansoor. Totowa, N.J. : Humana Press, 2004. Clinical Hypertension and Vascular Diseases. P. 251-276.


Lahlil R, Lécuyer E, Herblot S, Hoang T
SCL assembles a multifactorial complex that determines glycophorin A expression.
Mol Cell Biol,24(4):1439-1452, 2004.

Lamolet B, Poulin G, Chu K, Guillemot F, Tsai M-J, Drouin J

Tpit-independent function neurod1(beta2) in pituitary corticotroph differentiation.

Mol Endocrinol,

18(4):995-1003, 2004.


Latour S, Veillette A

The SAP family of adaptors in immune regulation.

Semin Immunol,

16(6):409-419, 2004.


Levesque K, Finzi A, Binette J, Cohen ÉA
Role of CD4 receptor down-regulation during HIV-1 infection.
Curr HIV Res,2(1):51-59, 2004.

Lin JW, Biankin AV, Horb ME, Ghosh B, Prasad NB, Yee NS, Pack MA, Leach SD

Differential requirement for ptf1a in endocrine and exocrine lineages of developing zebrafish pancreas. 

Dev Biol,

270(2):474-486, 2004.


Lips DJ, Bueno OF, Wilkins BJ, Purcell NH, Kaiser RA, Lorenz JN, Voisin L, Saba-El-Leil MK, Meloche S, Pouysségur J, Pagès G, De Windt LJ, Doevendans PA, Molkentin JD
MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo.
Circulation,109(16):1938-1941, 2004.

Llamas B, Deschepper CF


"Identification and validation of loci and candidate genes linked to cardiac hypertrophy". in Molecular cardiology: Methods and Protocols . Edited by Zhongjie Sun. Totowa, N.J : Humana Press, 2004. Methods in Molecular Medicine ; 112. P. 321-337

Lochard N, Thibault G, Silversides DW, Touyz RM, Reudelhuber TL

Chronic production of angiotensin IV in the brain leads to hypertension that is reversible with an angiotensin II AT1 receptor antagonist.

Circ Res,

94(11):1451-1457, 2004.


Lupotti FA, Zimmer A, Daronat M, Foster FS, Van Der Steen AFW, Cloutier G
Effects of aggregation of red cells and linear velocity gradients on the correlation-based method for quantitative IVUS blood flow at 20 MHz.
Ultrasound Med Biol,30(2):205-214, 2004.

Makrigiannis AP, Rousselle E, Anderson SK

Independent control of ly49g alleles: Implications for NK cell repertoire selection and tumor cell killing.

J Immunol,

172(3):1414-1425, 2004.


Martin R, Lahlil R, Damert A, Miquerol L, Nagy A, Keller G, Hoang T
SCL interacts with VEGF to suppress apoptosis at the onset of hematopoiesis.
Development,131(3):693-702, 2004.

Moreau, P., Laplante, M.-A., Beaucage, P., de Champlain, J

Angiotensin : Endothelin interactions.

in : Angiotensin. Edited by Thomas Unger, Bernward A.Schölkens. New York, N.Y. : Springer-Verlag, 2004. Handbook of Experimental Pharmacology ; 163. P. 149-170.


Mouchantaf R, Watt HL, Sulea T, Seidah NG, Alturaihi H, Patel YC, Kumar U

Prosomatostatin is proteolytically processed at the amino terminal segment by subtilase SKI-1.

Regul Pept,

120(1-3):133-140, 2004.


Nejjari M, Berthet V, Rigot V, Laforest S, Jacquier M-F, Seidah NG, Remy L, Bruyneel E, Scoazec J-Y, Marvaldi J, Luis J
Inhibition of proprotein convertases enhances cell migration and metastases development of human colon carcinoma cells in a rat model.
Am J Pathol,164(6):1925-1933, 2004.

Neves MF, Endemann D, Amiri F, Virdis A, Pu Q, Rozen R, Schiffrin EL
Small artery mechanics in hyperhomocysteinemic mice: Effects of angiotensin II.
J Hypertens,22(5):959-966, 2004.

Ongali B, Campos MM, Petcu M, Rodi D, Cloutier F, Chabot JG, Thibault G, Couture R

Expression of kinin B1 receptors in the spinal cord of streptozotocin-diabetic rat.

Neuroreport,

15(16):2463-2466, 2004.


Pan Q, Gollapudi AS, Dave VP

Biochemical evidence for the presence of a single CD3{delta} and CD3{gamma} chain in surface T cell receptor/CD3 complex.

J Biol Chem,

279(49):51068-51074, 2004.


Papapetropoulos A, Fulton D, Lin MI, Fontana J, McCabe TJ, Zoellner S, Garcia-Cardeña G, Zhou Z, Gratton J-P, Sessa WC
Vanadate is a potent activator of endothelial nitric-oxide synthase: Evidence for the role of the serine/threonine kinase Akt and the 90-kDa heat shock protein.
Mol Pharmacol,65(2):407-415, 2004.

Pladys P, Cambonie G, Thibault G, Lahaie I, Lê NLO, Abran D, Nuyt AM

Role of brain and peripheral angiotensin II in hypertension and altered arterial baroreflex programmed during fetal life in rat.

Pediatr Res,

55(6):1042-1049, 2004.


Poirier L, de Champlain J, Larochelle P, Lamarre-Cliche M, Lacourcière Y
A comparison of the efficacy and duration of action of telmisartan, amlodipine and ramipril in patients with confirmed ambulatory hypertension.
Blood Press Monit,9(5):231-236, 2004.

Posner SF, Vaslet CA, Jurofcik M, Lee A, Seidah NG, Nillni EA
Stepwise posttranslational processing of progrowth hormone-releasing hormone (proGHRH) polypeptide by furin and PC1.
Endocrine,23(2-3):199-214, 2004.

Proteau MF, Rousselle E, Makrigiannis AP

Mapping of the BALB/c Ly49 cluster defines a minimal natural killer cell receptor gene repertoire.

Genomics,

84(4):669-677, 2004.


Pulichino A-M, Vallette-Kasic S, Couture C, Brue T, Drouin J
Mutations du facteur de transcription Tpit et différenciation hypophysaire.
Med Sci (Paris),20(11):1009-1013, 2004.

Pulichino A-M, Vallette-Kasic S, Drouin J

Transcriptional regulation of pituitary gland development: Binary choices for cell differentiation.

Curr Opin Endocrinol Diabetes,

11(1):13-17, 2004.


Pullikotil P, Vincent M, Nichol ST, Seidah NG

Development of protein-based inhibitors of the proprotein of convertase SKI-1/S1P: Processing of SREBP-2, ATF6 and a viral glycoprotein.

J Biol Chem,

279(17):17338-17347, 2004.


Qiu W, Avramoglu RK, Dubé N, Chong TM, Naples M, Au C, Sidiropoulos KG, Lewis GF, Cohn JS, Tremblay ML, Adeli K

Hepatic PTP-1B expression regulates the assembly and secretion of apolipoprotein B-containing lipoproteins: Evidence from protein tyrosine phosphatase-1B overexpression, knockout, and RNAi studies.

Diabetes,

53(12):3057-3066, 2004.


Quarello P, Forni M, Barberis L, Defilippi C, Campagnoli MF, Silvestro L, Frattini A, Chalhoub N, Vacher J, Ramenghi U
Severe malignant osteopetrosis caused by a GL gene mutation.
J Bone Miner Res,19(7):1194-1199, 2004.

Rabah N, Gauthier DJ, Gauthier D, Lazure C

Improved PC1/3 production through recombinant expression in insect cells and larvae.

Protein Expr Purif

37(2):377-384, 2004.


Reudelhuber TL
Primary reninism or renin-secreting tumors.
in : Secondary Hypertension: Clinical Presentation, Diagnosis, and Treatment. Edited by George A. Mansoor. Totowa, N.J. : Humana Press, 2004. Clinical Hypertension and Vascular Diseases. P. 109-116.

Robert F, Pokholok DK, Hannett NM, Rinaldi NJ, Chandy M, Rolfe A, Workman JL, Gifford DK, Young RA

Global Position and Recruitment of HATs and HDACs in the Yeast Genome.

Mol Cell,

16(2):199-209, 2004.


Robson JD, Davidson D, Veillette A

Inhibition of the Jun N-terminal protein kinase pathway by SHIP-1, a lipid phosphatase that interacts with the adaptor molecule Dok-3.

Mol Cell Biol,

24(6):2332-2343, 2004.


Roy A, Drapeau V

Une saine alimentation est-ce encore possible en 2004 ?

Le Médecin du Québec,

39(2):103-110, 2004.


Roy DJ
Medical ethics, history of the Americas: Canada. In : Encyclopedia of Bioethics. Edited by Stephen G. Post. 3rd ed. Farmington Hills, Minn. : Thomson/Gale, 2004. P. 1540-1547.

Roy DJ
Devrions-nous tenter de modifier les gènes des générations futures?
L'Observatoire de la génétique,2004.

Roy DJ
Euthanasia and withholding treatment. In : Oxford Textbook of Palliative Medicine. Edited by Derek Doyle, Geoffrey Hanks, Nathan I. Cherny, Sir Kenneth Calman. 3rd ed. Oxford : Oxford University Press, 2004. P. 84-97.

Roy DJ
For her whom I did not know.
J Palliat Care,20(1):3-4, 2004.

Roy DJ
On listening to time passing.
J Palliat Care,20(2):67-68, 2004.

Roy DJ
Palliative care in a technological age.
J Palliat Care,20(4):267-268, 2004.

Roy DJ
Humanity: idea, image, reality.
J Palliat Care,20(3):131-132, 2004.

Ruel IL, Couture P, Cohn JS, Bensadoun A, Marcil M, Lamarche B

Evidence that hepatic lipase deficiency in humans is not associated with proatherogenic changes in HDL composition and metabolism.

J Lipid Res,

45(8):1528-1537, 2004.


Sairam MR, Balla A, Yang Y, Danilovich N, Wang M

Androgen excess, abnormal ovarian development and associated pathologies in genetically altered FORKO female mice: A paradigm for exploring hyperandrogenism. In: Proceedings of the 18th World Congress on Fertility and Sterility (IFFS 2004), Montreal, Canada 23-28 May 2004. Edited by Karena Grundy. Amsterdam : Elsevier, 2004. International Congress Series ; 1271. P. 296-299.

Santos RAS, Ferreira AJ, Nadu AP, Braga ANG, De Almeida AP, Campagnole-Santos MJ, Baltatu O, Iliescu R, Reudelhuber TL, Bader M

Expression of an angiotensin-(1-7)-producing fusion protein produces cardioprotective effects in rats.

Physiol Genomics,

17(3):292-299, 2004.


Savoia C, Schiffrin EL

New treatments for hypertension. In : The Year in Hypertension: 2004. Edited by H. Gavras. Oxford, U.K. : Clinical Publishing, 2004. P. 231-255.

Savoia C, Schiffrin EL

Significance of recently identified peptides in hypertension: Endothelin, natriuretic peptides, adrenomedullin, leptin.

Med Clin North Am,

88(1):39-63, 2004.


Schiffrin EL
Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment.
Am J Hypertens,17(12):1192-1200, 2004.

Schiffrin EL
Renin-angiotensin inhibitors and vascular effects. In : Angiotensin, Part II.
Edited by Thomas Unger, Bernward A.Schölkens. Berlin : Springer-Verlag, 2004. Handbook of experimental pharmacology; 163. P. 65-78.

Schiffrin EL

The many targets of aldosterone.

Hypertension,

43(5):938-940, 2004.


Schiffrin EL
Vascular stiffening and arterial compliance: Implications for systolic blood pressure.
Am J Hypertens,17(12 Part 2):S39-S48, 2004.

Schiffrin EL, Touyz RM
From bedside to bench to bedside: Role of renin-angiotensin-aldosterone system in remodeling of resistance arteries in hypertension.
Am J Physiol Heart Circ Physiol,287(2):H435-H446, 2004.

Schiller, P. W., Weltrowska, G., Schmidt, R., Nguyen, T. M. D., Berezowska, I., Lemieux, C., Chung, N. N., Carpenter, K., Wilkes, B. C.

Structural and pharmacological aspects of peptidomimetics

in : Drug Discovery Strategies and Methods.
Edited by Alexandros Makriyannis, Diane Biegel. New York, N.Y. Marcel Dekker, Inc., 2004. P. 147-173.


Schwahn BC, Wendel U, Lussier-Cacan S, Mar M-H, Zeisel SH, Leclerc D, Castro C, Garrow TA, Rozen R

Effects of betaine in a murine model of mild cystathionine-{beta}-synthase deficiency. 

Metabolism,

53(5):594-599, 2004.


Seidah NG, Chrétien M

Proprotein convertase 1

in : Handbook of Proteolytic Enzymes. Volume 2: Cysteine, Serine and Threonine Peptidases. Edited by Alan J.Barrett, Neil D.Rawlings, J.Fred Woessner. 2nd ed. San Diego : Elsevier Academic Press, 1998. P. 1861-1864.


Seidah NG, Chrétien M

Proprotein convertase 2

in : Handbook of Proteolytic Enzymes. Volume 2: Cysteine, Serine and Threonine Peptidases. Edited by Alan J.Barrett, Neil D.Rawlings, J.Fred Woessner. 2nd ed. San Diego : Elsevier Academic Press, 1998. P. 1865-1868.


Seidah NG, Chrétien M
Proprotein convertase 4
in : Handbook of Proteolytic Enzymes. Volume 2: Cysteine, Serine and Threonine Peptidases. Edited by Alan J.Barrett, Neil D.Rawlings, J.Fred Woessner. 2nd ed. San Diego : Elsevier Academic Press, 1998. P. 1868-1870.

Seidah NG, Chrétien M

Proprotein convertase 5

in : Handbook of Proteolytic Enzymes. Volume 2: Cysteine, Serine and Threonine Peptidases. Edited by Alan J.Barrett, Neil D.Rawlings, J.Fred Woessner. 2nd ed. San Diego : Elsevier Academic Press, 1998. P. 1874-1877.


Seidah NG, Chrétien M

Proprotein convertase 7

in : Handbook of Proteolytic Enzymes. Volume 2: Cysteine, Serine and Threonine Peptidases. Edited by Alan J.Barrett, Neil D.Rawlings, J.Fred Woessner. 2nd ed. San Diego : Elsevier Academic Press, 1998. P. 1877-1880.


Sriraman V, Sairam MR, Jagannadha RA

Evaluation of relative role of LH and FSH in restoration of spermatogenesis using ethanedimethylsulphonate-treated adult rats.

Reprod Biomed Online,

8(2):167-174, 2004.


Stawowy P, Kallisch H, Kilimnik A, Margeta C, Seidah NG, Chretien M, Fleck E, Graf K

Proprotein convertases regulate insulin-like growth factor 1-induced membrane-type 1 matrix metalloproteinase in VSMCs via endoproteolytic activation of the insulin-like growth factor-1 receptor.

Biochem Biophys Res Commun,

321(3):531-538, 2004.


Stawowy P, Kallisch H, Veinot JP, Kilimnik A, Prichett W, Goetze S, Seidah NG, Chretien M, Fleck E, Graf K

Endoproteolytic activation of alphav integrin by proprotein convertase PC5 is required for vascular smooth muscle cell adhesion to vitronectin and integrin-dependent signaling.

Circulation,

109(6):770-776, 2004.


Stawowy P, Margeta C, Kallisch H, Seidah NG, Chrétien M, Fleck E, Graf K
Regulation of matrix metalloproteinase MT1-MMP/MMP-2 in cardiac fibroblasts by TGF-beta1 involves furin-convertase.
Cardiovasc Res,63(1):87-97, 2004.

Tabet F, Savoia C, Schiffrin EL, Touyz RM
Differential calcium regulation by hydrogen peroxide and superoxide in vascular smooth muscle cells from spontaneously hypertensive rats.
J Cardiovasc Pharmacol,44(2):200-208, 2004.

Tapias A, Auriol J, Forget D, Enzlin JH, Schärer OD, Coin F, Coulombe B, Egly J-M

Ordered conformational changes in damaged DNA induced by nucleotide excision.

J Biol Chem,

279(18):19074-19083, 2004.


Toro R, Saadi I, Kuburas A, Nemer M, Russo AF

Cell-specific activation of the ANF promoter by PITX2 and MEF2A.

J Biol Chem,

279(50):52087-52094, 2004.


Tosh D, Horb ME
How cells change their phenotype.
In : Handbook of Stem Cells. Volume 2 : Adult and Fetal. Edited by Robert Lanza, Helen Blau, Douglas Melton, Malcolm Moore, E. Donnall Thomas, Catherine Verfaillie, Irving Weissman, Michael West. Amsterdam : Elsevier Academic Press, 2004. P. 139-145.

Tourwé D, Tóth G, Carlens G, Tömböly C, Péter A, Schiller PW

Beta-MethyI substitution of the cha residue in Dmt-Tic-Cha-Phe peptides provides highly potent delta antagonists.

In: Peptide Revolution: Genomics, Proteomics and Therapeutics. Proceedings of the Eighteenth American Peptide Symposium, July 19-23, 2003. Boston, MA, U.S.A. Edited by Michael Chorev, Tomi K.Sawyer. San Diego, Calif. : American Peptide Society, 2004. P.582-583 


Touyz RM

Magnesium in clinical medicine.

Front Biosci,

9:1278-1293, 2004.


Touyz RM
Reactive oxygen species and angiotensin II signaling in vascular cells: Implications in cardiovascular disease.
Braz J Med Biol Res,37(8):1263-1273, 2004.

Touyz RM
Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: What is the clinical significance?
Hypertension,44(3):248-252, 2004.

Touyz RM, Campbell N, Logan A, Gledhill N, Petrella R, Padwal R
The 2004 Canadian recommendations for the management of hypertension: Part III - Lifestyle modifications to prevent and control hypertension.
Can J Cardiol,20(1):55-59, 2004.

Touyz RM, Schiffrin EL

Reactive oxygen species in vascular biology: Implications in hypertension.

Histochem Cell Biol,

122(4):339-352, 2004.


Touyz RM, Yao G, Viel E, Amiri F, Schiffrin EL
Angiotensin II and endothelin-1 regulate MAP kinases through different redox-dependent mechanisms in human vascular smooth muscle cells.
J Hypertens,22(6):1141-1149, 2004.

Turcotte K, Gauthier S, Mitsos L-M, Shustik C, Copeland NG, Jenkins NA, Fournet J-C, Jolicoeur P, Gros P

Genetic control of myeloproliferation in BXH-2 mice.

Blood,

103(6):2343-2350, 2004.


Twickler TB, Dallinga-Thie GM, Cohn JS, Chapman MJ

Elevated remnant-like particle cholesterol concentration: A characteristic feature of the atherogenic lipoprotein phenotype.

Circulation,

109(16):1918-1925, 2004.


Utting O, Sedgmen BJ, Watts TH, Shi X, Rottapel R, Iulianella A, Lohnes D, Veillette A

Immune functions in mice lacking Clnk, an SLP-76-related adaptor expressed in a subset of immune cells.

Mol Cell Biol,

24(13):6067-6075, 2004.


Veillette A

Adaptors in immune regulation.

Semin Immunol,

16(6):349, 2004.


Veillette A

SLAM family receptors regulate immunity with and without SAP-related adaptors.

J Exp Med,

199(9):1175-1178, 2004.


Veillette A

Specialised adaptors in immune cells.

Curr Opin Cell Biol,

16(2):146-155, 2004.


Veinot JP, Prichett-Pejic W, Picard P, Parks W, Schwartz R, Seidah NG, Chretien M
Implications of proprotein Convertase 5 (PC5) in the arterial restenotic process in a porcine model.
Cardiovasc Pathol,13(5):241-250, 2004.

Virdis A, Fritsch Neves M, Amiri F, Touyz RM, Schiffrin EL
Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice.
J Hypertens,22(3):535-542, 2004.

Wan H, Umstot ES, Szeto HH, Schiller PW, Desiderio DM

Quantitative analysis of [Dmt1]DALDA in ovine plasma by capillary liquid chromatography-nanospray ion-trap mass spectrometry.

J Chromatogr B Analyt Technol Biomed Life Sci,

803(1):83-90, 2004.


Wang Y, Coulombe R, Cameron DR, Thauvette L, Massariol M-J, Amon LM, Fink D, Titolo S, Welchner E, Yoakim C, Archambault J, White PW
Crystal structure of the E2 transactivation domain of human papillomavirus type 11 bound to a protein interaction inhibitor.
J Biol Chem,279(8):6976-6985, 2004.

Wassef H, Bernier L, Davignon J, Cohn JS
Synthesis and secretion of ApoC-I and ApoE during maturation of human SW872 liposarcoma cells.
J Nutr,134(11):2935-2941, 2004.

Weltrowska G, Lemieux C, Chung NN, Schiller PW

A chimeric opioid peptide with mixed (mu) agonist/(delta) antagonist properties.

J Pept Res,

63(2):63-68, 2004.


Weltrowska G, Lu Y, Lemieux C, Chung NN, Schiller PW

A novel cyclic enkephalin analogue with potent opioid antagonist activity.

Bioorg Med Chem Lett,

14(18):4731-4733, 2004.


Weltrowska G, Lu Y, Lemieux C, Chung NN, Schiller PW
A potent cyclic opioid peptide antagonist lacking an N-terminal amino group.
In: Peptide Revolution: Genomics, Proteomics and Therapeutics. Proceedings of the Eighteenth American Peptide Symposium, July 19-23, 2003. Boston, MA, U.S.A. Edited by Michael Chorev, Tomi K.Sawyer. San Diego, Calif. : American Peptide Society, 2004. P. 582-583.

Weng X, Priceputu E, Chrobak P, Poudrier J, Kay DG, Hanna Z, Mak TW, Jolicoeur P

CD4+ T cells from CD4C/HIVNef transgenic mice show enhanced activation in vivo with impaired proliferation in vitro but are dispensable for the development of a severe AIDS-like organ disease.

J Virol,

78(10):5244-5257, 2004.


Wilkes BC, De Léan A, Schiller PW
Molecular dynamics simulations of BNP binding to the NPRA receptor dimer.
In: Peptide Revolution: Genomics, Proteomics and Therapeutics. Proceedings of the Eighteenth American Peptide Symposium, July 19-23, 2003. Boston, MA, U.S.A. Edited by Michael Chorev, Tomi K.Sawyer. San Diego, Calif. : American Peptide Society, 2004. P. 455-456.

Witkowska R, Chung NN, Schiller PW, and Zabrocki J

Synthesis and biological activity profile of new analogues of the cyclic opioid peptide H-Tyr-c[D-Cys-Gly-Phe(pNO2)-D-Cys]-NH2 containing (S)-{alpha}-hydroxymethylcysteine in place of cysteine.

J Pept Sci,

2004.


Wu L, Wang R, de Champlain J, Wilson TW
Beneficial and deleterious effects of rosiglitazone on hypertension development in spontaneously hypertensive rats.
Am J Hypertens,17(9):749-756, 2004.

Wu R, Laplante MA, de Champlain J
Prevention of angiotensin II-induced hypertension, cardiovascular hypertrophy and oxidative stress by acetylsalicylic acid in rats.
J Hypertens,22(4):793-801, 2004.

Yao X-J, Rougeau N, Ghislaine D, Lemay J, Cohen ÉA
Analysis of HIV-1 Vpr determinants responsible for cell growth arrest in Saccharomyces cerevisiae.
Retrovirology,1(1):1-11, 2004.

Zang M-X, Li Y, Wang H, Wang J-B, Jia H-T

Cooperative interaction between the basic-helix-loop-helix transcription factor dHAND and myocyte enhancer factor-2C regulates myocardial gene expression.

J Biol Chem,

279(52):54258-54263, 2004.


Zhao K, Zhao G-M, Wu D, Soong Y, Birk AV, Schiller PW, Szeto HH

Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death and reperfusion injury.

J Biol Chem,

279(33):34682-34690, 2004.